K
Kancera AB
F:3EE0
Kancera AB
F:3EE0
Price:
0.0001
EUR
Market Cap:
€12.1k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Kancera AB
F:3EE0
|
SE |
|
T
|
Tlou Energy Ltd
LSE:TLOU
|
AU |
|
Jig-Saw Inc
TSE:3914
|
JP |
|
Angi Inc
NASDAQ:ANGI
|
US |
|
Y
|
Y Optics Manufacture Co Ltd
KOSDAQ:066430
|
KR |
|
Mayora Indah Tbk PT
F:D7V
|
ID |
|
Chuang's China Investments Ltd
HKEX:298
|
HK |
|
Union Steel Holdings Ltd
SGX:BLA
|
SG |
|
SVG Tech Group Co Ltd
SZSE:300331
|
CN |
|
Vitec Group Plc
LSE:VTC
|
UK |
|
R
|
Revenga Ingenieros SA
MAD:RSS
|
ES |
|
Fleetwood Ltd
ASX:FWD
|
AU |
|
Triumph Group Inc
NYSE:TGI
|
US |
|
A
|
AMD Industries Ltd
NSE:AMDIND
|
IN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 3EE0.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
3EE0
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
3EE0 Competitors Multiples
Kancera AB Competitors
Kancera AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
K
|
Kancera AB
F:3EE0
|
19.4m EUR | 0 | -0.4 | -0.1 | -0.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.5B USD | 6.2 | 90.7 | 15 | 20.8 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
362.4B USD | 111.6 | -1 741.9 | 16 180.3 | -1 827 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.6B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173B USD | 5.9 | 20.4 | 12.8 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.4B USD | 9.6 | 29 | 21.8 | 22.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.7B USD | 5.7 | 18.2 | 13.7 | 15.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD | 3.1 | 34.5 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
